Alibaba Health Information Technology Limited

SEHK:241 Lagerbericht

Marktkapitalisierung: HK$47.3b

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Alibaba Health Information Technology Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

Alibaba Health Information Technology hat ein durchschnittliches jährliches Gewinnwachstum von 48.4% verzeichnet, während die Branche Consumer Retailing ein Gewinnwachstum gewachsen unter 31.5% jährlich einen Rückgang. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 33.7% pro Jahr. Alibaba Health Information Technology's return on equity is 5.1%, und die Nettomargen betragen 2.9%.

Wichtige Informationen

48.4%

Wachstumsrate der Gewinne

48.4%

EPS-Wachstumsrate

Consumer Retailing Wachstum der Industrie28.3%
Wachstumsrate der Einnahmen33.7%
Eigenkapitalrendite5.1%
Netto-Marge2.9%
Nächste Ertragsaktualisierung27 May 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%

Apr 21
Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%

Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?

Apr 16
Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?

Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger

Mar 29
Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

Mar 12
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Jan 17
With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Jan 07
Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)

Dec 15
Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)

Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price

Sep 28
Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price

Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price

Jul 02
Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?

Jun 11
Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?

Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Jun 22
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?

Dec 01
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?

Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Oct 15
Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Aug 12
Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)

Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price

Jun 25
Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price

These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts

May 30
These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts

Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%

May 27
Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%

The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising

Mar 23
The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising

Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?

Mar 05
Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?

How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?

Feb 15
How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?

Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 31
Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?

If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today

Dec 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today

Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 16
Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?

Dec 01
Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?

Aufschlüsselung der Einnahmen und Ausgaben

Wie Alibaba Health Information Technology Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

SEHK:241 Einnahmen, Ausgaben und Erträge (CNY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Sep 2328,2188175,336673
30 Jun 2327,4916755,196675
31 Mar 2326,7635335,055678
31 Dec 2224,7423324,701704
30 Sep 2222,7201284,346730
30 Jun 2221,649-694,410729
31 Mar 2220,578-2664,474729
31 Dec 2119,146-2164,171623
30 Sep 2117,714-1673,868517
30 Jun 2116,616913,501470
31 Mar 2115,5183493,135424
31 Dec 2014,0803132,836385
30 Sep 2012,6422782,537347
30 Jun 2011,1191362,289300
31 Mar 209,596-72,041253
31 Dec 198,465-31,833252
30 Sep 197,33411,624250
30 Jun 196,215-401,416235
31 Mar 195,096-821,208219
31 Dec 184,264-911,034194
30 Sep 183,432-100859169
30 Jun 182,937-104760147
31 Mar 182,443-107661126
31 Dec 171,876-152563123
30 Sep 171,310-196465120
30 Jun 17892-202371114
31 Mar 17475-208276109
31 Dec 16285-20123399
30 Sep 1694-19419190
30 Jun 1676-19318283
31 Mar 1657-19217376
31 Dec 1544-17317568
30 Sep 1532-15417760
30 Jun 1531-11814547
31 Mar 1530-8111334
31 Dec 1431-607429
30 Sep 1431-393523
30 Jun 1427-363519
31 Mar 1422-313314
31 Dec 1316-35347
30 Sep 1312-39360
30 Jun 1312-36340

Qualität der Erträge: 241 hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: 241Die aktuellen Gewinnspannen (2.9%) sind höher als im letzten Jahr (0.6%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 241 ist in den letzten 5 Jahren profitabel geworden und hat seinen Gewinn um 48.4% pro Jahr gesteigert.

Beschleunigtes Wachstum: 241Das Gewinnwachstum des Unternehmens im letzten Jahr (536.3%) übertrifft seinen 5-Jahres-Durchschnitt (48.4% pro Jahr).

Erträge im Vergleich zur Industrie: 241 Das Gewinnwachstum im vergangenen Jahr (536.3%) übertraf das der Branche Consumer Retailing 3.1% .


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 241Die Eigenkapitalrendite des Unternehmens (5.1%) wird als niedrig angesehen.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren